QA: Veracyte INC in us_health_services/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001384101_2020_Veracyte_INC.pdf

Logs

info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.3713075255718969, 'aggregate_val': 153101000, 'exp_sum': 111646000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 36729000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 52389000, 'ResearchAndDevelopmentExpense': 17204000, 'remainder_Expenses': 5324000}}

Graph

Absolute values for 0001384101, Veracyte INC

  xvar xval
0 IntangibleAssets 2,725,000
1 AssetsNonCurrent 10,245,000
2 AssetsCurrent 187,687,000
3 PropertyPlantAndEquipment 8,933,000
4 remainder_Assets 65,622,000
5 LongTermLiabilities 12,200,000
6 LiabilitiesCurrent 17,469,000
7 remainder_Liabilities 6,088,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 36,077,000
10 GeneralAndAdministrativeExpense 29,029,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 53,691,000
15 ResearchAndDevelopmentExpense 14,851,000
16 remainder_Expenses 1,847,000
17 remainder_Revenues 120,368,000
18 remainder_NetIncome 0
19 remainder_ComprehensiveNetIncome 2,528,000
  yvar yval
0 Assets 275,212,000
1 Liabilities 35,757,000
2 Expenses 135,495,000
3 Revenues 120,368,000
4 StockholdersEquity 239,455,000
5 NetIncome -15,127,000
6 ComprehensiveNetIncome -12,599,000
7 BaseVar 284,680,000
8 EconomicCapitalRatio 4.20

Edgar->Model Mapping

Feature Distribution

Change over Time